Cargando…
Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands
[Image: see text] Immunotherapy is considered a promising approach for cancer treatment. An important strategy for cancer immunotherapy is the use of cancer vaccines, which have been widely used for cancer treatment. Despite the great potential of cancer vaccines for cancer treatment, their therapeu...
Autores principales: | Rostamizadeh, Leila, Molavi, Ommoleila, Rashid, Mohsen, Ramazani, Fatemeh, Baradaran, Behzad, Lavasanaifar, Afsaneh, Lai, Raymond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences (TUOMS Publishing Group)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124882/ https://www.ncbi.nlm.nih.gov/pubmed/35677663 http://dx.doi.org/10.34172/bi.2022.23896 |
Ejemplares similares
-
The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma
por: Zhang, Ying, et al.
Publicado: (2014) -
Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy
por: Jafari, Sevda, et al.
Publicado: (2023) -
Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin
por: Hassankhani Rad, Ashkan, et al.
Publicado: (2020) -
Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands
por: Chew, Valerie, et al.
Publicado: (2013) -
Decoration of Anti-CD38 on Nanoparticles Carrying a STAT3 Inhibitor Can Improve the Therapeutic Efficacy Against Myeloma
por: Huang, Yung-Hsing, et al.
Publicado: (2019)